Biden to nominate cancer surgeon Monica Bertagnolli to lead National Institutes of Health

Biden to nominate cancer surgeon Monica Bertagnolli to lead National Institutes of Health


Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022.

Jeff Chiu | AP

President Joe Biden will nominate Dr. Monica Bertagnolli, a cancer surgeon, to lead the National Institutes of Health, the White House announced Monday.

Bertagnolli is currently the director of the National Cancer Institute, the first woman to lead the organization.

NIH, which has a budget of about $45 billion, funds medical research across the U.S. and around the world. The agency played a pivotal role in developing the messenger RNA technology that underlies the Covid-19 vaccine made by Moderna.

Biden in a statement called Bertagnolli “a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.”

The NIH has been without a Senate-confirmed director since Dr. Francis Collins, who had led the agency for more than 12 years, stepped down in December 2021 in the midst of the coronavirus pandemic. Dr. Lawrence Tabak is currently serving as acting director of the agency.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Bertagnolli previously was a professor of cancer surgery at Harvard Medical School, and a surgeon at Brigham and Women’s Hospital in Boston.

Biden said that as head of the National Cancer Institute, she has helped advance the White House’s cancer moonshot initiative, which aims to slash the death from the disease by 50% over the next 25 years.

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said.



Source

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Health

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]

Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Health

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]

Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Health

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]

Read More